These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33508041)

  • 1. Hematopoietic cell-mediated dissemination of murine cytomegalovirus is regulated by NK cells and immune evasion.
    Zhang S; Springer LE; Rao HZ; Espinosa Trethewy RG; Bishop LM; Hancock MH; Grey F; Snyder CM
    PLoS Pathog; 2021 Jan; 17(1):e1009255. PubMed ID: 33508041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.
    Munks MW; Pinto AK; Doom CM; Hill AB
    J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.
    Holtappels R; Thomas D; Podlech J; Geginat G; Steffens HP; Reddehase MJ
    J Virol; 2000 Feb; 74(4):1871-84. PubMed ID: 10644360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse Cytomegalovirus m153 Protein Stabilizes Expression of the Inhibitory NKR-P1B Ligand Clr-b.
    Aguilar OA; Sampaio IS; Rahim MMA; Samaniego JD; Tilahun ME; Krishnamoorthy M; Popović B; Babić M; Krmpotić A; Treanor B; Margulies DH; Allan DSJ; Makrigiannis AP; Jonjić S; Carlyle JR
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
    MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
    J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern of CD11c on lung immune cells after disseminated murine cytomegalovirus infection.
    Liao Y; Liu X; Huang Y; Huang H; Lu Y; Zhang Y; Shu S; Fang F
    Virol J; 2017 Jul; 14(1):132. PubMed ID: 28720115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection.
    Lathbury LJ; Allan JE; Shellam GR; Scalzo AA
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2605-13. PubMed ID: 8887497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells.
    Walton SM; Mandaric S; Torti N; Zimmermann A; Hengel H; Oxenius A
    PLoS Pathog; 2011 Aug; 7(8):e1002214. PubMed ID: 21901102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response.
    Mitrović M; Arapović J; Jordan S; Fodil-Cornu N; Ebert S; Vidal SM; Krmpotić A; Reddehase MJ; Jonjić S
    J Virol; 2012 Feb; 86(4):2165-75. PubMed ID: 22156533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection.
    Arapović J; Arapović M; Golemac M; Traven L; Tomac J; Rumora D; Ražić E; Krmpotić A; Jonjić S
    Med Microbiol Immunol; 2015 Jun; 204(3):335-44. PubMed ID: 25809566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice.
    Rodriguez M; Sabastian P; Clark P; Brown MG
    J Immunol; 2004 Nov; 173(10):6312-8. PubMed ID: 15528370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.
    Teoh JJ; Gamache AE; Gillespie AL; Stadnisky MD; Yagita H; Bullock TN; Brown MG
    J Immunol; 2016 Dec; 197(11):4360-4370. PubMed ID: 27798162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
    Morello CS; Ye M; Spector DH
    J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
    Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
    Front Immunol; 2018; 9():991. PubMed ID: 29867968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells improve control of friend virus infection in mice persistently infected with murine cytomegalovirus.
    Francois S; Peng J; Schwarz T; Duppach J; Gibbert K; Dittmer U; Kraft AR
    Retrovirology; 2013 Jun; 10():58. PubMed ID: 23738889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stochastic Episodes of Latent Cytomegalovirus Transcription Drive CD8 T-Cell "Memory Inflation" and Avoid Immune Evasion.
    Griessl M; Renzaho A; Freitag K; Seckert CK; Reddehase MJ; Lemmermann NAW
    Front Immunol; 2021; 12():668885. PubMed ID: 33968074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity.
    Fleming P; Davis-Poynter N; Degli-Esposti M; Densley E; Papadimitriou J; Shellam G; Farrell H
    J Virol; 1999 Aug; 73(8):6800-9. PubMed ID: 10400778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Salivary Gland Acts as a Sink for Tissue-Resident Memory CD8(+) T Cells, Facilitating Protection from Local Cytomegalovirus Infection.
    Thom JT; Weber TC; Walton SM; Torti N; Oxenius A
    Cell Rep; 2015 Nov; 13(6):1125-1136. PubMed ID: 26526997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.
    Holtappels R; Simon CO; Munks MW; Thomas D; Deegen P; Kühnapfel B; Däubner T; Emde SF; Podlech J; Grzimek NK; Oehrlein-Karpi SA; Hill AB; Reddehase MJ
    J Virol; 2008 Jun; 82(12):5781-96. PubMed ID: 18367531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.